Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Inflammatory biomarkers in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) treated with coramitug: post hoc analysis of a phase 2 randomized trial
Nowell M Fine1,2; Wansuk Choi3; Nelson Ferreira4; Bjarke Follin4; Marianna Fontana5; Mathew S Maurer6; Uzoma Obiaka3; Julie L Rosenthal7; Peter-Paul Zwetsloot8,9; Kenichi Tsujita10
MATERIALS AVAILABLE
Coming soon
Monday, 12 October 2026
09:50 - 09:57
MST
Add to calendar
SHORT ORAL PRESENTATION
Prevalence of Cardiovascular Inflammation and Associated Patient Characteristics and Biomarker Profiles Across the Heart Failure Spectrum in the United States: Results From the POSEIDON Study
Marat Fudim, MD, MHS1,2; Johanna P. Contreras, MD, MSc3; Homam Ibrahim, MD4; Pablo E. Pergola, MD, PhD5; Ashley Goss, PhD6; Marco Petti, MD6; Jeffrey R. Skaar, PhD6; Udi Fainberg, MD6; Matthew Budoff, MD7